ReviewHematology. American Society of Hematology. Education Program2025
Targeted triplet therapies incorporating FLT3 or IDH inhibitors: ready for prime time?
Himachandana Atluri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it